Dale Okuno

This profile gathers the share dealings of Dale Okuno in Pure Bioscience, Inc. In total, 8 filings cover trades dated from 19 February 2019 to 9 March 2020.

The open-market side counts 3 purchases for €674k alongside 2 sales for €208k. Taken together, the purchases exceed the sales by €465k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 3 share grants. So far in 2020, the count stands at no purchases and 2 sales.

The median purchase comes to €223k. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 33% of cases, with a median move of -22.5%. This is a record of the past, not a forecast.

The latest filing, published on 12 March 2020, reports a share grant of €395k in Pure Bioscience, Inc. The most recent open-market purchase was published on 3 October 2019, 2,594 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.